Taiwan FDA registration 6d6ed4b4fe89565e91d3277293e48f59
EasyTest blood glucose/cholesterol/uric acid/heme/triglycerides monitoring system
TW: 易立測 血糖/膽固醇/尿酸/血紅素/三酸甘油脂 監測系統
Taiwan·Risk Class 2·BIOPTIK TECHNOLOGY, INC.·Registered Aug 09, 2021 – Mar 15, 2026ExpiredRegistration details
- Analysis ID
- 6d6ed4b4fe89565e91d3277293e48f59
Company information
- Manufacturer
- BIOPTIK TECHNOLOGY, INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- BIOPTIK TECHNOLOGY, INC.
Product details
- Intended Use
- This product is for in vitro testing only, measured with fresh fingertip microvascular whole blood to quantify blood glucose, cholesterol, uric acid, heme and triglycerides. This product can be used by self-testing and healthcare professionals, but is not intended for testing of newborns.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1775 Uric acid testing system;; A.1705 Triglyceride test system;; A.1345 Glucose Test System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Aug 09, 2021
- Expiry Date
- Mar 15, 2026
About this record
Access comprehensive regulatory information for EasyTest blood glucose/cholesterol/uric acid/heme/triglycerides monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6d6ed4b4fe89565e91d3277293e48f59 and manufactured by BIOPTIK TECHNOLOGY, INC.. The authorized representative in Taiwan is BIOPTIK TECHNOLOGY, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices